EGFR and glioblastoma: The average levels of EPHA2 and EGFR were significantly higher (P<0.05; two-tailed t-test) in GBM patients (n=17) than in healthy controls (n=15); PDPN level was similar in both groups (P=0.15; Supplementary Fig. 14a).